Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Profoxydim is a post-emergence herbicide belonging to the cyclohexenone (cyclic ketone) class, primarily used for the control of annual and perennial grassy weeds in crops such as rice, soybeans, and tobacco[1][7]. Its mechanism of action involves inhibition of acetyl-CoA carboxylase (ACCase), an enzyme essential for fatty acid biosynthesis in plants. By blocking this enzyme, profoxydim disrupts cell membrane formation and other vital cellular processes in susceptible grasses[10]. It is not intended or approved for pharmaceutical use in humans or animals. Profoxydim has been associated with certain hazards including skin sensitization, suspected carcinogenicity, and reproductive toxicity[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on profoxydim.